Marius Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MARIUS PHARMS LLC, and what generic alternatives to MARIUS PHARMS LLC drugs are available?
MARIUS PHARMS LLC has one approved drug.
There are four US patents protecting MARIUS PHARMS LLC drugs.
There are eighteen patent family members on MARIUS PHARMS LLC drugs in eleven countries.
Summary for Marius Pharms Llc
International Patents: | 18 |
US Patents: | 4 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Marius Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | 11,590,146 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | 10,576,090 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | 10,576,089 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | 11,617,758 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Marius Pharms Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2682111 | ⤷ Subscribe |
European Patent Office | 2968137 | ⤷ Subscribe |
European Patent Office | 2519230 | ⤷ Subscribe |
China | 105188670 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.